OR Royalties Inc.
OR • Gold
$34.78
▼ -0.02 (-0.06%)
Current price
EarningsLatest report: Mar 31, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$5.77B
Growth
—
Cash Flow
3/5
Trend
Mostly stable
Evidence
Stable or improving margins · 74.3%Positive revenue growth · 9.3%Positive free cash flow · 1.13Manageable debt level · 0.01Healthy liquidity · 4.53
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 6, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$34.78
Change-0.06%
Market Cap$5.77B
52W Range27.54 - 48.06
Beta1.32
Gross Margin83.38%
Oper. Margin72.92%
Profit Margin74.30%
Debt/Eq0.01
Current Ratio4.53
Quick Ratio4.53
FCF 5Y-11.53%
Price$34.78
Change-0.06%
Market Cap$5.77B
52W Range27.54 - 48.06
Beta1.32
Gross Margin83.38%
Oper. Margin72.92%
Profit Margin74.30%
Debt/Eq0.01
Current Ratio4.53
Quick Ratio4.53
FCF 5Y-11.53%
Target$40.33
Target Upside15.96%
Target Median$42.00
Target Range34.00 - 45.00
Volume590.39K
Avg Volume970.99K
EPS Surprise0.06
Investment DNA
How strong this company looks for long-term investors
79
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
93/100
Price Attractiveness
Cheap or expensive today
38/100
Why this score▼
Stable or improving margins · 74.3%Positive revenue growth · 9.3%Positive free cash flow · 1.13Manageable debt level · 0.01Healthy liquidity · 4.53
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$34.00
Mean
$40.33
Median
$42.00
High
$45.00
🧾
No insider activity
No recent insider transactions available.